GSK3B and colonic neoplasm: (2014) [6], an increase in ROS generation was demonstrated at different concentrations of LiCl in SW-480 colon cancer cells (a different cell line from the one used in our study) through the ROS/GSK-3β/NF-κB pathway, thereby suppressing cell proliferation.